Allergy Immunotherapy Market Traverse 10.85% CAGR by Eminent Players as Allergy Therapeutics, Merck KGaA (Allergopharma), and Circassia, etc

Market Research Future (MRFR)’s latest report reveals that the Global Allergy Immunotherapy Market is set to exhibit a steep rise in growth registering a CAGR of 10.85% during the forecast period 2017 to 2023. The market has been estimated to reach a valuation of USD 4,324.7 Mn by the end of 2023. Considering the global scenario of the market, Europe is the top contributor in this market. The Western Europe is holding the largest market share and is expected to reach USD 954.1 million by 2023. Rise in prevalence of chronic diseases like allergy, asthma, diabetes and hypertension drive this market in Europe. According to the European Academy of Allergy and Clinical Immunology, Belgium, in 2015 nearly 150 million European citizens were suffering from chronic allergic diseases and it is estimated that by 2025 more than 50% of all Europeans will suffer from at least one type of allergy. Due to high prevalence of allergic rhinitis & skin allergy, and increasing awareness regarding treatment of allergies, US Allergy Immunotherapy market was valued USD 329.2 million in 2016.

Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, and rising healthcare expenditure. Asia Pacific Allergy Immunotherapy market is expected to grow at a CAGR of 11.32% during the forecast period. Middle East & Africa is expected to have limited growth. UAE is dominating this market by holding 53.5% of the Middle East & Africa market share.

To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/1517

Industry Developments:

In August 2018, Arrayit Corporation, life sciences, and personalized medicine company announced its partnership with multiple providers of allergen immunotherapy products for allergy testing to treat patients with allergy and asthma.

In August 2018, Astria Sunnyside Hospital announced the availability of an allergy testing and treatment program. Allergy treatment options being offered at the hospital include sublingual immunotherapy and regular allergy shots.

Allergy Immunotherapy Market - Overview

The widespread prevalence of allergies has fueled demand in the allergy immunotherapy market. The trend is anticipated to perpetuate over the next couple of years. According to a report published by the World Health Organization (WHO), approximately 10-40% of the population was suffering from allergy in 2013.

The increasing patient pool coupled with the availability of advanced allergy treatment procedures has augured well for the players of the allergy immunotherapy market. The market is expected to remain highly lucrative in the foreseeable future, and the increased investments in clinical trials and research & development activities are set to catapult the market on an upward trajectory.

The developing healthcare sector in emerging markets in Latin America, Asia, etc. are anticipated to steer the growth of the allergy immunotherapy market. Other favorable factors encouraging the growth of the market include increasing awareness of the treatment, technological advancement, growth strategies of major players, etc.

Key Players for Global Allergy Immunotherapy Market

Market Research Future (MRFR) recognizes the following companies as the key players in Allergy Immunotherapy Market: There are plenty of large and small market players which operate in this market all over the globe.

Some of the key players profiled in the report are ALK Abello A/S (Denmark), DBV Technologies (France), Stallergenes Greer (UK), HAL Allergy Group (Netherlands), Allergy Therapeutics (UK), Merck KGaA (Allergopharma) (Germany), and Circassia (UK) among others.

Segments for Global Allergy Immunotherapy Market

By allergy type, the global allergy immunotherapy market has been segmented into allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies. The allergic rhinitis segment currently accounts for a dominant share of the market. Meanwhile, the peanut allergy segment is estimated to register a CAGR of 11.3%.

By treatment, the allergy immunotherapy market is segmented into Subcutaneous Immunotherapy (SCIT), sublingual immunotherapy, and Specific Immunotherapy (SIT). The Subcutaneous Immunotherapy (SCIT) segment holds the largest share of the market and is projected to reach a valuation of USD 2,089.2 by 2023.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

List of Table

TABLE 1 Global Allergy Immunotherapy Market, By Allergy Type, 2013-2023 (USD Million)

TABLE 2 Global Allergy Immunotherapy Market For Allergy Rhinitis, By Region, 2013-2023 (USD Million)

TABLE 3 Global Allergy Immunotherapy Market For Allergic Asthma, By Region, 2013-2023(USD Million)

TABLE 4 Global Allergy Immunotherapy Market For Peanut Allergy, By Region, 2013-2023(USD Million)

TABLE 5 Global Allergy Immunotherapy Market For Cat Allergy, By Region, 2013-2023 (USD Million)

Continued…

List of Figures

FIGURE 1 Global Allergy Immunotherapy Market, By Allergy Type, 2016 (%)

FIGURE 2 Global Allergy Immunotherapy Market, By Treatment, 2016 (%)

FIGURE 3 Global Allergy Immunotherapy Market, By Region, 2016 (%)

FIGURE 4 Global ALLERGY IMMUNOTHERAPY MARKET: Market Structure

FIGURE 5 RESEARCH PROCESS

Continued…

Do You Have Specific Requirement? Ask To Our Experts https://www.marketresearchfuture.com/enquiry/1517

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.